Palantir patient data tech rejected by many NHS trusts in England
Summary
Many NHS trusts in England are choosing not to use Palantir’s patient data technology, saying they can find better or similar alternatives. Although some trusts found the system helpful for managing waiting lists and surgery scheduling, many others stopped using it after trials or never adopted it, raising questions about its effectiveness and value.Key Facts
- The £330 million Palantir federated data platform (FDP) was introduced to help integrate NHS patient data.
- Since March 2024, at least 16 NHS trusts and health boards have decided not to use Palantir’s system.
- Some trusts said Palantir’s technology duplicates existing systems or offers limited benefits.
- The contract with Palantir lasts seven years, but the government may end it early using a break clause.
- Palantir’s involvement in the NHS has faced protests linked to its other contracts with the Israeli military and U.S. homeland security.
- Palantir’s chief lobbyist, former Labour MP Tom Watson, said if other companies had better technology, they would have competed openly.
- Parliamentary committees, including the Commons’ science and technology committee, have recommended ending the Palantir contract.
- Campaign groups like Medact highlight that NHS trusts have other effective data systems available and urge a smooth transition away from Palantir.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
